ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone:: A systematic review

Schroder, Fritz; Kattan, Michael W.
European Urology2008-8DOI: 10.1016/j.eururo.2008.05.022
112被引2阅读
引用收藏
分享

摘要

Context: The sensitivity and specificity profile of measuring levels of prostate-specific antigen (PSA) to select men for prostate biopsy is not optimal. This has prompted the construction of nomograms and artificial neural networks (ANNs) to increase the performance of PSA measurements. Objective: A systematic review of nomograms and ANNs designed to predict the risk of a positive prostate biopsy for cancer was conducted in order to determine their value versus measuring PSA levels alone. Evidence acquisition: Medical Literature Analysis and Retrieval System Online (U.S. National Library of Medicine's life science database; MEDLINE) was searched using the terms "nomogram" "artificial neural network" and "prostate cancer" for dates up to and including July 2007 and was supplemented by manual searches of reference lists. Included studies used an assessment tool to examine the risk of a positive prostate biopsy in a man without a known cancer diagnosis. Intramodel comparisons with evaluation of PSA levels alone, and intermodel comparisons of area under the curve (AUC) from receiver operating characteristic (ROC) curves were conducted. individual case examples were also used for comparisons. Evidence synthesis: Twenty-three studies examining 36 models were included. With the exception of two studies, all the models had AUC values of 0.70 or greater, with eight reporting an AUC of >= 0.80 and four (all ANNs) reporting an AUC >= 0.85, with variable validation status. Fourteen studies compared the AUC with PSA levels alone: all showed a benefit from using AUCs which varied from 0.02 to 0.26. Of the 16 external validation comparisons, in 13 the AUC was lower in the external population than in the model population. Conclusions: Nomograms and ANNs produce improvements in AUC over measurement of PSA levels alone, but many lack external validation. Where this is available, the benefits are often diminished, although most remain significantly better than with evaluation of PSA levels alone. In men without additional risk factors, PSA cutoff values alone provide a relatively precise risk estimate, but if additional risk factors are known, PSA values alone are less accurate.

学科与关键词

关键词
prostate cancerscreeningprostate specific antigennomogramartificial neural network
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
European Urology
发表日期
2008-08
卷期
第 54 卷, 第 2 期
页码
274-290
DOI
10.1016/j.eururo.2008.05.022
语言
ENGLISH
成果收录
SCIE

作者

  • S

    Schroder, Fritz (第一作者)

  • K

    Kattan, Michael W.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417